Syra Health EBITDA 2022-2023 | SYRA
Syra Health ebitda from 2022 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Syra Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-3 |
| 2022 | $-2 |
| 2021 | $-0 |
| Syra Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-09-30 | $-0 |
| 2022-12-31 | |
| 2022-09-30 | $-0 |
| 2021-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.012B | $0.006B |
| Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
| Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
| 10x Genomics (TXG) | United States | $3.022B | 0.00 |
| Azenta (AZTA) | United States | $3.015B | 163.85 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
| Enovis (ENOV) | United States | $2.779B | 20.60 |
| Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
| Privia Health (PRVA) | United States | $2.238B | 99.26 |
| Schrodinger (SDGR) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 47.56 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Standard BioTools (LAB) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.451B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
| Pulmonx (LUNG) | United States | $0.342B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.128B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.17 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.094B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| ETAO (ETAO) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |